Amoxicillin trihydrate mixture with potassium clavulanate (4:1)

This combination of amoxicillin trihydrate and potassium clavulanate (4:1 ratio) is a broad-spectrum, orally bioavailable antibiotic. It inhibits bacterial cell wall synthesis, exerting bactericidal activity. It is widely used in research for studying β-lactamase-producing pathogens in both in vitro susceptibility assays and in vivo infection models.